Posted on April 8, 20214/8/21
Spanish SEFC Eyes Up Drug Evaluation Overhaul Through “Multidisciplinary Collaboration”
Posted on April 5, 20214/5/21
Last Week in Review: 3/29/2021 – 4/2/2021
Posted on April 2, 20214/2/21
IQWiG Tasked by G-BA to Collect Application-Related Data on CAR-T Therapies
Posted on March 31, 20213/31/21
AIFA Introduces Simplified Pricing, Reimbursement Negotiation Procedure for Parallel Imported Drugs
Posted on March 29, 20213/29/21
U.S. Senators Reintroduce FAIR Drug Pricing Act Requiring Transparency Surrounding Drug Price Increases
Posted on March 29, 20213/29/21
Last Week in Review: 3/22/2021 – 3/26/2021
Posted on March 26, 20213/26/21
Italy’s AGCM Proposes Increased Public-Private Integration, Scrapping Laws that Prohibit Competition Among Biosimilars, Generics
Posted on March 25, 20213/25/21
Sanders’ 3 Acts Latest Entry in United States’ Prescription Drug Price Saga
Posted on March 24, 20213/24/21
Chengdu Launches Rare Disease Drug Program with Capped Reimbursement
Posted on March 24, 20213/24/21